Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys

October 31, 2017

REGISTER for free or LOG IN to view this content

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presentation

TCT 2017

Aortic Valve

Up Next

Presentation TCT 2017

CLI and Lower Extremity Intervention: Devices and Techniques for Complex Disease in the Office Interventional Suites

Presenter: Brian G. DeRubertis

October 31, 2017

More slides +

Presentation TCT 2017

Management of Unilateral RAS With Uncontrolled Hypertension on Three Meds: Pro Additional Medical Management

Presenter: Robert D. Safian

October 31, 2017

Presentation TCT 2017

TCT 41: Initial Pre-clinical Porcine and Ex-Vivo Human Coronary Images With a Hybrid Intravascular Ultrasound and Optical Coherence Tomography System

Presenter: Ulf Landmesser

October 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

slide